BAUSCH & LOMB'S OPCON A TO BE AVAILABLE OVER-THE-COUNTER
Executive Summary
BAUSCH & LOMB'S OPCON A TO BE AVAILABLE OVER-THE-COUNTER by the end of 1994 following FDA's approval of the company's Rx-to- OTC switch application on June 8. The antihistamine/decongestant eye drops (pheniramine .315%/naphazolinc HCl .027%) "will be available in food and drug stores and mass merchandise outlets across the country by late 1994," Bausch & Lomb said. The NDA (20- 065) switch application, which was filed in March 1990, included clinical trial data and manufacturing information, Bausch & Lomb said.